title: Metastatic mechanisms in follicular cell-derived thyroid cancer.
abstract: Thyroid cancer incidence is rising annually largely related to enhanced detection and early stage well-differentiated primary tumors. The prognosis for patients with early stage thyroid cancer is outstanding with most patients being cured with surgery. In selected cases, I-131 is administered to treat known or suspected residual or metastatic disease. Even patients with loco-regional metastases typically have an outstanding long-term prognosis, albeit with monitoring and occasional intervention for residual or recurrent disease. By contrast, individuals with distant metastases from thyroid cancer, particularly older patients with larger metastatic burdens and those with poorly differentiated tumors, have a poor prognosis. Patients with metastatic anaplastic thyroid cancer have a particularly poor prognosis. Published clinical trials indicate that transient disease control and partial remissions can be achieved with kinase inhibitor therapy directed toward angiogenic targets and that in some cases I-131 uptake can be enhanced. However, the direct targets of activity in metastatic lesions are incompletely defined and clear evidence that these treatments increase the duration or quality of life of patients is lacking, underscoring the need for improved knowledge regarding the metastatic process to inform the development of new therapies. In this review, we will focus on current data and hypotheses regarding key regulators of metastatic dormancy, metastatic progression, and the role of putative cancer stem cells.
authors.affiliation: Division of Surgical Oncology, Department of Surgery Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, The Ohio State University College of Medicine, Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, 1581 Dodd Drive, Room 565 McCampbell Hall, Columbus, Ohio 43210, USA.
authors.forename: John E
authors.initials: JE
authors.lastname: Phay
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Ringel
mesh_terms: D018263:Adenocarcinoma, Follicular / Q000473:pathology*; D000818:Animals; D006801:Humans; D009362:Neoplasm Metastasis
keywords: angiogenesis; metastases; metastases suppressors; thyroid carcinoma; tumor stem cells
references.citation: Cancer Res. 2013 Feb 1;73(3):1037-45
references.pmid: 23345162
references.citation: Science. 1998 Nov 6;282(5391):1145-7
references.pmid: 9804556
references.citation: Nature. 2010 Oct 28;467(7319):1114-7
references.pmid: 20981102
references.citation: Nature. 2010 Oct 28;467(7319):1109-13
references.pmid: 20981101
references.citation: Mol Cell Endocrinol. 2010 May 28;321(1):94-102
references.pmid: 19835928
references.citation: J Clin Endocrinol Metab. 2007 Sep;92(9):3681-8
references.pmid: 17609303
references.citation: Science. 2011 Mar 25;331(6024):1565-70
references.pmid: 21436444
references.citation: Clin Endocrinol (Oxf). 1989 Dec;31(6):655-65
references.pmid: 2627756
references.citation: Nat Rev Cancer. 2007 Nov;7(11):834-46
references.pmid: 17957189
references.citation: Cancer Metastasis Rev. 2012 Dec;31(3-4):593-603
references.pmid: 22706779
references.citation: Clin Cancer Res. 2011 Sep 15;17(18):5850-7
references.pmid: 21673068
references.citation: Nature. 2007 Dec 6;450(7171):903-7
references.pmid: 18026089
references.citation: Cancer. 1985 Aug 1;56(3):531-8
references.pmid: 2408737
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2803-8
references.pmid: 17296934
references.citation: Clin Cancer Res. 2005 May 15;11(10):3678-85
references.pmid: 15897564
references.citation: Laryngoscope. 2010 Jul;120(7):1383-90
references.pmid: 20578104
references.citation: Cancer Cell. 2009 Mar 3;15(3):232-9
references.pmid: 19249681
references.citation: Mol Cancer Res. 2009 Mar;7(3):330-8
references.pmid: 19276181
references.citation: Cancer Res. 2010 Nov 1;70(21):8874-85
references.pmid: 20959469
references.citation: Clin Exp Metastasis. 2009;26(6):517-26
references.pmid: 19306109
references.citation: Nature. 2012 Feb 15;482(7386):529-33
references.pmid: 22343890
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11707-12
references.pmid: 16857736
references.citation: Semin Cancer Biol. 2012 Jun;22(3):187-93
references.pmid: 22774232
references.citation: J Clin Endocrinol Metab. 2009 May;94(5):1493-9
references.pmid: 19258410
references.citation: J Cell Mol Med. 2009 Aug;13(8B):2236-2252
references.pmid: 18681906
references.citation: J Cell Biol. 2012 Aug 6;198(3):281-93
references.pmid: 22869594
references.citation: J Clin Endocrinol Metab. 2001 Apr;86(4):1447-63
references.pmid: 11297567
references.citation: Endocr Relat Cancer. 2008 Dec;15(4):1069-74
references.pmid: 18719091
references.citation: Nature. 2009 Jun 25;459(7250):1126-30
references.pmid: 19458618
references.citation: Clin Cancer Res. 1998 Feb;4(2):287-94
references.pmid: 9516913
references.citation: Thyroid. 2006 Jun;16(6):537-44
references.pmid: 16839255
references.citation: J Clin Invest. 1985 Nov;76(5):1992-2002
references.pmid: 4056062
references.citation: Rev Endocr Metab Disord. 2000 Apr;1(3):183-96
references.pmid: 11708296
references.citation: Cancer Res. 2012 May 1;72(9):2162-71
references.pmid: 22549946
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14825-30
references.pmid: 16203990
references.citation: Nature. 1981 Jul 9;292(5819):154-6
references.pmid: 7242681
references.citation: N Engl J Med. 2012 Mar 8;366(10):883-892
references.pmid: 22397650
references.citation: J Clin Endocrinol Metab. 2013 Feb;98(2):474-82
references.pmid: 23293329
references.citation: Clin Cancer Res. 2004 Dec 15;10(24):8152-62
references.pmid: 15623589
references.citation: Endocr Relat Cancer. 2009 Mar;16(1):17-44
references.pmid: 18987168
references.citation: PLoS One. 2013;8(1):e54302
references.pmid: 23372702
references.citation: Cell. 2009 Dec 24;139(7):1315-26
references.pmid: 20064377
references.citation: Lancet. 2002 Aug 31;360(9334):683-9
references.pmid: 12241875
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12396-400
references.pmid: 21746894
references.citation: Cancer Cell. 2005 Sep;8(3):227-39
references.pmid: 16169467
references.citation: Clin Exp Immunol. 2013 Jan;171(1):36-45
references.pmid: 23199321
references.citation: J Clin Endocrinol Metab. 2001 Aug;86(8):3975-80
references.pmid: 11502841
references.citation: Thyroid. 2012 Sep;22(9):884-9
references.pmid: 22827579
references.citation: Cancer Cell. 2008 Jan;13(1):58-68
references.pmid: 18167340
references.citation: J Clin Endocrinol Metab. 2013 May;98(5):E829-36
references.pmid: 23533233
references.citation: J Clin Invest. 2010 Jun;120(6):2030-9
references.pmid: 20501944
references.citation: Nature. 2004 Feb 26;427(6977):787
references.pmid: 14985739
references.citation: Cancer Metastasis Rev. 1989 Aug;8(2):98-101
references.pmid: 2673568
references.citation: J Immunol. 1999 Mar 1;162(5):2842-9
references.pmid: 10072532
references.citation: Keio J Med. 2012;61(2):47-56
references.pmid: 22760023
references.citation: Cell Stem Cell. 2007 Nov;1(5):555-67
references.pmid: 18371393
references.citation: Am J Pathol. 1993 Jun;142(6):1938-44
references.pmid: 8389529
references.citation: Endocrinology. 2009 Apr;150(4):1970-5
references.pmid: 19074581
references.citation: J Endocrinol. 2008 Sep;198(3):471-87
references.pmid: 18550786
references.citation: Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10649-54
references.pmid: 20498063
references.citation: Pathol Res Pract. 1995 Sep;191(9):838-41
references.pmid: 8606862
references.citation: APMIS. 2008 Jul-Aug;116(7-8):586-601
references.pmid: 18834404
references.citation: Nat Rev Cancer. 2002 Oct;2(10):795-803
references.pmid: 12360282
references.citation: Biochem Biophys Res Commun. 2009 Jul 31;385(3):307-13
references.pmid: 19450560
references.citation: Science. 2008 Sep 26;321(5897):1841-4
references.pmid: 18755941
references.citation: Br Med J. 1954 Sep 11;2(4888):607-10
references.pmid: 13190204
references.citation: J Clin Endocrinol Metab. 2012 Jun;97(6):E934-43
references.pmid: 22466343
references.citation: Cancer Discov. 2013 May;3(5):520-33
references.pmid: 23365119
references.citation: Cancer Res. 2007 Feb 15;67(4):1411-4
references.pmid: 17308076
references.citation: Curr Opin Genet Dev. 2011 Feb;21(1):42-9
references.pmid: 21145726
references.citation: Clin Endocrinol (Oxf). 2010 May;72(5):702-8
references.pmid: 20447069
references.citation: Thyroid. 2011 May;21(5):487-92
references.pmid: 21476892
references.citation: Br J Cancer. 1987 Dec;56(6):814-9
references.pmid: 2829956
references.citation: Lancet. 2000 Jan 15;355(9199):165-9
references.pmid: 10675114
references.citation: Cancer Res. 2009 Feb 15;69(4):1302-13
references.pmid: 19190339
references.citation: Cell. 2010 May 14;141(4):583-94
references.pmid: 20478252
references.citation: Clin Cancer Res. 2012 Jul 15;18(14):3719-21
references.pmid: 22679177
references.citation: Curr Opin Chem Biol. 2002 Jun;6(3):399-404
references.pmid: 12023122
references.citation: N Engl J Med. 1993 Apr 29;328(17):1237-43
references.pmid: 8464435
references.citation: J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
references.pmid: 16684830
references.citation: PLoS One. 2012;7(8):e42976
references.pmid: 22927944
references.citation: J Clin Endocrinol Metab. 2010 May;95(5):2325-33
references.pmid: 20207826
references.citation: J Clin Endocrinol Metab. 2001 Feb;86(2):656-8
references.pmid: 11158026
references.citation: Endocr Rev. 2013 Jun;34(3):439-55
references.pmid: 23575762
references.citation: Cell Stem Cell. 2007 Sep 13;1(3):313-23
references.pmid: 18371365
references.citation: Sci Transl Med. 2012 Mar 28;4(127):127ps8
references.pmid: 22461638
references.citation: Nat Rev Cancer. 2009 Apr;9(4):274-84
references.pmid: 19308067
references.citation: Eur J Cancer. 2010 May;46(7):1181-8
references.pmid: 20304630
references.citation: N Engl J Med. 1971 Nov 18;285(21):1182-6
references.pmid: 4938153
references.citation: Physiol Rev. 1992 Jul;72(3):667-97
references.pmid: 1320763
references.citation: J Clin Endocrinol Metab. 1999 Nov;84(11):4043-9
references.pmid: 10566647
references.citation: Cancer Res. 2009 Jun 1;69(11):4885-93
references.pmid: 19487299
references.citation: Biophys J. 2009 Aug 19;97(4):1013-21
references.pmid: 19686648
references.citation: Semin Cancer Biol. 2007 Jun;17(3):233-40
references.pmid: 16569505
references.citation: Surgery. 2001 May;129(5):552-8
references.pmid: 11331447
references.citation: J Clin Endocrinol Metab. 2009 Jun;94(6):2199-203
references.pmid: 19293266
references.citation: Cell Stem Cell. 2012 Apr 6;10(4):398-411
references.pmid: 22482505
references.citation: Science. 2009 Nov 27;326(5957):1216-9
references.pmid: 19965464
references.citation: Cancer Res. 2009 Dec 15;69(24):9245-53
references.pmid: 19951996
references.citation: Free Radic Biol Med. 2012 Feb 15;52(4):735-46
references.pmid: 22206977
references.citation: Endocr Relat Cancer. 2008 Mar;15(1):51-8
references.pmid: 18310275
references.citation: Nature. 2001 May 31;411(6837):613-7
references.pmid: 11385580
references.citation: J Natl Cancer Inst. 2012 Sep 5;104(17):1306-19
references.pmid: 22911670
references.citation: Am J Surg Pathol. 2002 Aug;26(8):1016-23
references.pmid: 12170088
references.citation: Eur J Endocrinol. 2013 Feb 15;168(3):343-9
references.pmid: 23211578
references.citation: Nature. 2011 Dec 07;481(7379):85-9
references.pmid: 22158103
references.citation: EMBO J. 2012 Jan 18;31(2):254-6
references.pmid: 22179697
references.citation: J Exp Med. 2012 Jul 2;209(7):1289-307
references.pmid: 22711876
references.citation: Clin Cancer Res. 2010 Jan 1;16(1):45-55
references.pmid: 20028757
references.citation: Endocr Pathol. 2013 Mar;24(1):1-10
references.pmid: 23435637
references.citation: J Clin Endocrinol Metab. 2011 Sep;96(9):2692-702
references.pmid: 21778219
references.citation: Nat Rev Endocrinol. 2011 Jul 26;7(10):609-16
references.pmid: 21788969
references.citation: Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16002-7
references.pmid: 21911392
references.citation: Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10889-94
references.pmid: 16832052
references.citation: Mod Pathol. 1995 Apr;8(3):252-6
references.pmid: 7617649
references.citation: J Clin Endocrinol Metab. 2003 Sep;88(9):4440-5
references.pmid: 12970322
references.citation: Proc Natl Acad Sci U S A. 2012 May 29;109(22):8699-704
references.pmid: 22589302
references.citation: Endocrinology. 2003 Jun;144(6):2644-9
references.pmid: 12746328
references.citation: Endocr Relat Cancer. 2010 Oct 29;17(4):989-99
references.pmid: 20817787
references.citation: J Natl Cancer Inst. 2007 Feb 21;99(4):309-21
references.pmid: 17312308
references.citation: Mod Pathol. 2003 Jan;16(1):43-8
references.pmid: 12527712
references.citation: Nature. 2012 Nov 1;491(7422):66-71
references.pmid: 23051751
references.citation: Genes Cancer. 2011 Dec;2(12):1117-33
references.pmid: 22866203
references.citation: Nat Rev Cancer. 2008 May;8(5):329-40
references.pmid: 18404148
references.citation: Endocrinology. 2006 Jun;147(6):3007-15
references.pmid: 16497809
references.citation: J Clin Endocrinol Metab. 2005 Sep;90(9):5432-40
references.pmid: 15998767
references.citation: Thyroid. 2013 Oct;23(10):1277-83
references.pmid: 23489023
references.citation: Cancer Res. 1988 Nov 15;48(22):6550-4
references.pmid: 2460224
references.citation: Discov Med. 2012 Aug;14(75):97-104
references.pmid: 22935206